IP Library Granted Patent US 8,440,789
Granted Patent B2
US 8,440,789 · App. 12/597,862 · Granted May 14, 2013

Pharmaceutical and/or cosmetic composition containing an active antioxydant principle and cell energy activator

Inventors: Claude Dal Farra (Opio, FR); Nouha Domloge (Valbonne, FR); Jean-Marie Botto (Valbonne, FR)
Assignee: Societe d'Extraction des Principes Actifs (Vincience)
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,440,789
App. No.
12/597,862
Granted
May 14, 2013
Kind
B2
Abstract

A cosmetic or pharmaceutical composition, and particularly dermatological composition, comprising, in a physiologically adapted medium, as active principle, polypeptides or peptides, and methods of administering a composition capable of increasing cell energy and to protect the skin from oxidative damage. Also, a cosmetic treatment procedure aimed at protecting the skin and the skin appendages from external aggressions and to combat skin aging.

Claims (29)

1. A composition comprising:

an active principle in a physiologically acceptable medium, said active principle comprising a peptide wherein,

said peptide comprises from 5 to 6 residues of amino acids, and

said peptide has a sequence according to formula (I):

R 1 -Ala- Val- Leu- Ala- Gly-(AA) p -R 2

in which

AA represents any amino acid, and p is 0 or 1,

R 1 represents the primary amino function of the amino acid N-terminal, free or substituted by a protector group selected from the group consisting of an acetyl group, a benzyl group, a tosyl group and a benzyloxycarbonyl group, and

R 2 represents the hydroxyl function of carboxyl acid of the amino acid C-terminal, free or substituted by a protector group selected from (i) an alkyl chain from C 1 to C 20 , or (ii) an NH 2 group, an NHY group or an NYY group with Y representing an alkyl chain from C 1 to C 4 .

2. The composition according to claim 1 , wherein said peptide consists of the sequence Ala-Val -Leu-Ala-Gly-Asp-NH 2 (SEQ ID NO: 1).

3. The composition according to claim 1 , wherein said peptide consists of the sequence Ala-Val -Leu-Ala-Gly-Asp (SEQ ID NO: 2).

4. The composition according to claim 1 , wherein said peptide possesses at least one functional group protected by a protector group, said protector group being either at least one of (i) an acylation or an acetylation of the amino-terminal end and (ii) an amidation or an esterification of the carboxyterminal end.

5. The composition according to claim 1 , wherein said active principle is present in the composition in a concentration between 0.0005 and 500 ppm approximately compared to the total weight of the composition.

6. The composition according to claim 5 , wherein said active principle is present in the composition in a concentration between 0.01 and 5 ppm compared to the total weight of the composition.

7. The composition according to claim 1 , wherein said active principle made soluble in one or more solvents cosmetically or pharmaceutically acceptable selected from the group consisting of water, glycerol, ethanol, propylene glycol, butylene glycol, dipropylene glycol, ethoxyl or propoxyl diglycols, cyclic polyols, petroleum jelly, a vegetable oil and mixtures thereof.

8. The composition according to claim 1 , wherein the composition is in a topical application form.

9. The composition according to claim 1 , further comprising at least one other active agent promoting the action of said active principle.

10. The composition according to claim 9 , wherein said other active agent is selected from the group consisting of active agents having an antioxidant action, active agents stimulating the synthesis of macromolecules, and active agents stimulating energy metabolism.

11. A method of preparing a cosmetic composition or a pharmaceutical composition according to claim 1 , comprising adding an effective amount of active principle to a physiologically acceptable medium.

12. A method of increasing the synthesis of intracellular ATP in the cells of the skin, comprising administering to a subject in need thereof a cosmetic composition according to claim 1 having an effective amount of active principle.

13. A method of increasing the activity or the synthesis of the enzyme transprenyl transferase and/or of the coenzyme Q10 in the cells of the skin, comprising administering to a subject in need thereof a cosmetic composition according to claim 1 having an effective amount of active principle.

14. A method of protecting the skin and the skin appendages against all types of external aggressions, comprising administering to a subject in need thereof a cosmetic composition according to claim 1 having an effective amount of active principle.

15. A method of preventing or treating damage caused to the skin and the skin appendages by UV rays, comprising administering to a subject in need thereof a cosmetic composition according to claim 1 having an effective amount of active principle.

16. A method of protecting the skin and the skin appendages from oxidative damage, comprising administering to a subject in need thereof a cosmetic composition according to claim 1 having an effective amount of active principle.

17. A method of preventing or treating the skin signs of aging and/or photoaging, comprising administering to a subject in need thereof a cosmetic composition according to claim 1 having an effective amount of active principle.

18. A method for preparing a pharmaceutical composition according to claim 1 for preventing or combating pathologies linked to the oxidation processes, comprising adding an effective amount of active principle to a physiologically acceptable medium.

19. A method of treating the skin and the skin appendages from external aggressions and to combat skin aging, comprising topically applying to the skin or the skin appendages of a subject in need thereof a cosmetic composition according to claim 1 .

20. The composition according to claim 1 , wherein said peptide consists of the sequence Ala-Val -Leu-Ala-Gly (SEQ ID NO: 3).

21. The composition according to claim 1 , wherein said peptide consists of the sequence Ala-Val -Leu-Ala-Gly-NH 2 (SEQ ID NO: 4).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2010
From: FARRA, CLAUDE DAL; DOMLOGE, NOUHA; BOTTO, JEAN-MARIE
To: SOCIETE D'EXTRACTION DES PRINCIPES ACTIFS SA
Reel/Frame 024129/0702 →
Priority Claims (1)
FR 07 03063 · Apr 27, 2007 · national
Continuity (1)
Related Publication 20100184637A1 · Jul 22, 2010